95-13990. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 60, Number 110 (Thursday, June 8, 1995)]
[Notices]
[Page 30320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13990]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 16, 1995, Johnson & 
Johnson Pharmaceutical Partners, HC02 State Road 933, KMO.1 Mamey Ward, 
HC-02 Box 19250, Gurabo, Puerto Rico 00778-9629, made application to 
the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                 Drug                               Schedule            
------------------------------------------------------------------------
Alfentanil (9737)....................  II                               
Sufentanil (9740)....................  II                               
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
bulk distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than July 10, 1995.

    Dated: May 30, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-13990 Filed 6-7-95; 8:45 am]
BILLING CODE 4410-09-M